BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 33516062)

  • 1. Real-time fMRI neurofeedback amygdala training may influence kynurenine pathway metabolism in major depressive disorder.
    Tsuchiyagaito A; Smith JL; El-Sabbagh N; Zotev V; Misaki M; Al Zoubi O; Kent Teague T; Paulus MP; Bodurka J; Savitz J
    Neuroimage Clin; 2021; 29():102559. PubMed ID: 33516062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression.
    Young KD; Drevets WC; Dantzer R; Teague TK; Bodurka J; Savitz J
    Brain Behav Immun; 2016 Aug; 56():335-42. PubMed ID: 27091600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-Reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder.
    Zheng H; Teague TK; Yeh FC; Burrows K; Figueroa-Hall LK; Aupperle RL; Khalsa SS; Paulus MP; Savitz J
    Brain Behav Immun; 2022 Oct; 105():180-189. PubMed ID: 35853557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered task-based and resting-state amygdala functional connectivity following real-time fMRI amygdala neurofeedback training in major depressive disorder.
    Young KD; Siegle GJ; Misaki M; Zotev V; Phillips R; Drevets WC; Bodurka J
    Neuroimage Clin; 2018; 17():691-703. PubMed ID: 29270356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Clinical Trial of Real-Time fMRI Amygdala Neurofeedback for Major Depressive Disorder: Effects on Symptoms and Autobiographical Memory Recall.
    Young KD; Siegle GJ; Zotev V; Phillips R; Misaki M; Yuan H; Drevets WC; Bodurka J
    Am J Psychiatry; 2017 Aug; 174(8):748-755. PubMed ID: 28407727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between amygdala BOLD activity and frontal EEG asymmetry during real-time fMRI neurofeedback training in patients with depression.
    Zotev V; Yuan H; Misaki M; Phillips R; Young KD; Feldner MT; Bodurka J
    Neuroimage Clin; 2016; 11():224-238. PubMed ID: 26958462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time fMRI neurofeedback training of the amygdala activity with simultaneous EEG in veterans with combat-related PTSD.
    Zotev V; Phillips R; Misaki M; Wong CK; Wurfel BE; Krueger F; Feldner M; Bodurka J
    Neuroimage Clin; 2018; 19():106-121. PubMed ID: 30035008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-Time Functional Magnetic Resonance Imaging Amygdala Neurofeedback Changes Positive Information Processing in Major Depressive Disorder.
    Young KD; Misaki M; Harmer CJ; Victor T; Zotev V; Phillips R; Siegle GJ; Drevets WC; Bodurka J
    Biol Psychiatry; 2017 Oct; 82(8):578-586. PubMed ID: 28476207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emotion self-regulation training in major depressive disorder using simultaneous real-time fMRI and EEG neurofeedback.
    Zotev V; Mayeli A; Misaki M; Bodurka J
    Neuroimage Clin; 2020; 27():102331. PubMed ID: 32623140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression.
    Meier TB; Drevets WC; Teague TK; Wurfel BE; Mueller SC; Bodurka J; Dantzer R; Savitz J
    Brain Behav Immun; 2018 Jan; 67():59-64. PubMed ID: 28867283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting-state functional connectivity modulation and sustained changes after real-time functional magnetic resonance imaging neurofeedback training in depression.
    Yuan H; Young KD; Phillips R; Zotev V; Misaki M; Bodurka J
    Brain Connect; 2014 Nov; 4(9):690-701. PubMed ID: 25329241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.
    Savitz J; Drevets WC; Smith CM; Victor TA; Wurfel BE; Bellgowan PS; Bodurka J; Teague TK; Dantzer R
    Neuropsychopharmacology; 2015 Jan; 40(2):463-71. PubMed ID: 25074636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder.
    Savitz J; Drevets WC; Wurfel BE; Ford BN; Bellgowan PS; Victor TA; Bodurka J; Teague TK; Dantzer R
    Brain Behav Immun; 2015 May; 46():55-9. PubMed ID: 25686798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of the effects of sport-related concussion on serum kynurenine pathway metabolites.
    Meier TB; Nitta ME; Teague TK; Nelson LD; McCrea MA; Savitz J
    Brain Behav Immun; 2020 Jul; 87():715-724. PubMed ID: 32147388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder.
    Savitz J; Dantzer R; Meier TB; Wurfel BE; Victor TA; McIntosh SA; Ford BN; Morris HM; Bodurka J; Teague TK; Drevets WC
    Psychoneuroendocrinology; 2015 Dec; 62():54-8. PubMed ID: 26232650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time FMRI neurofeedback training of amygdala activity in patients with major depressive disorder.
    Young KD; Zotev V; Phillips R; Misaki M; Yuan H; Drevets WC; Bodurka J
    PLoS One; 2014; 9(2):e88785. PubMed ID: 24523939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum kynurenic acid is reduced in affective psychosis.
    Wurfel BE; Drevets WC; Bliss SA; McMillin JR; Suzuki H; Ford BN; Morris HM; Teague TK; Dantzer R; Savitz JB
    Transl Psychiatry; 2017 May; 7(5):e1115. PubMed ID: 28463241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced efficacy of CBT following augmentation with amygdala rtfMRI neurofeedback in depression.
    Compère L; Siegle GJ; Riley E; Lazzaro S; Strege M; Pacoe E; Canovali G; Barb S; Huppert T; Young K
    J Affect Disord; 2023 Oct; 339():495-501. PubMed ID: 37459978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.
    Savitz J; Dantzer R; Wurfel BE; Victor TA; Ford BN; Bodurka J; Bellgowan PS; Teague TK; Drevets WC
    Psychoneuroendocrinology; 2015 Feb; 52():200-11. PubMed ID: 25486577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.